Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516166 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
EnterprisewideAdd to Basket
Electronic (Online Access)Add to Basket
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Invacare Medical Device Company Intelligence Report

Espicom Business Intelligence Ltd, May 2011, Pages: 30


  Description  
   Table of Contents   
   Summary   
    
    
     
  Enquire before Buying   
  Send to a Friend   

In 2009, Invacare initiated a strategic plan that is focused on “glocalisation”, in which it will manage its business globally yet be flexible enough to meet local market needs. Some time ago, the company recognised that its product portfolio of highly-tailored regional products would not be cost-effective in a world of declining reimbursement. For example, French products were designed, engineered and sold primarily in France. That same business model was applied in each of the company’s regional businesses worldwide, leading to duplication in products and engineering, as well as inefficiencies in sourcing. Glocalisation will serve as a key driver of future growth and lower costs by simplifying the company’s product lines and eliminating unnecessary complexity.

Through this initiative, Invacare has begun to leverage its global purchasing power, research and development (R&D), engineering, systems and other support functions. As Invacare globalises, the company says it will eliminate redundant activities, increase agility, drive innovation, deliver profitable growth and reduce complexities both internally and externally for its customers. Glocalisation is expected to achieve annualised savings of US$100 million over a five-year period, which will drive gross margin expansion, allow for increased investment in R&D and help offset pricing/reimbursement pressures over time. In 2010, Invacare also established a new organisational structure that will allow senior management to accelerate the implantation of its global initiatives.

As Invacare looks to return to organic sales growth (+7% in 2008, -0.2% in 2009 and 1% in 2010), the company will pursue opportunities to:

- Expand its core business – Over the five years beginning in 2010, Invacare aims to double R&D spending for new product development funded by its savings from glocalisation. The company will focus on innovation, which the company believes has been a key ingredient to its success, and maximise market share opportunities within existing geographies.

- Explore new business opportunities beyond Invacare’s traditional product platforms, including therapeutic support surfaces and negative pressure wound therapy.

- Increase its presence in new markets, such as Latin America, China and Eastern Europe.

This company report provides:

Overview
- Key contact information
- Introduction to the company and its current activities
- Summary of its financial performance
- Who are the company’s major competitors?
- Key recent events in an “at a glance” format

Financial Review
- Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
- Table providing in-depth five-year financial analysis
- Employee data, including breakdown by company division and geographic location

Strategic Focus
- Investigates the company’s aims and its areas of focus

Products
- Core product areas, key brands, product approvals and launches Research and Development
- How much has been invested in R&D?
- Where is the research based?
- What alliances and agreements does the company have and with whom?

Manufacturing and Distribution
- Identifying the company’s manufacturing locations
- Sales and marketing facilities

Agreements
- With whom has the company reached agreements and what do they involve?
- Key contracts awarded

Mergers, Acquisitions, Minority Investments and Divestments

Litigation

Key Corporate Events



Customers who bought this item also bought

Wheelchairs (Powered and Manual) - Global Strategic Business Report

Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018

Medical Oxygen Systems - Global Strategic Business Report

Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015

Oxygen Concentrator Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018

Manual Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018

Global Respiratory Care Devices Market (2010 - 2015)

Power Assist Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017

Wheelchair Market Shares Strategies, and Forecasts, Worldwide, 2009 to 2015

Shimadzu Medical Device Company Intelligence Report



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds